| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 21 May 2026 | 18 May 2026 |
| Broach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the meeting of the Board of Directors of BROACH LIFECARE HOSPITAL LIMITED (the Company) is scheduled to be held on Thursday, May 21, 2026, at 04.00 p.m. at the registered office situated at 501, 5TH FLOOR, CORPORATE HOUSE, ABOVE BHARUCH ORTHOPAEDIC HOSPITAL, R K CASTA, BHARUCH-392001, GUJARAT, INDIA to, inter alia, transact following business: 1. To receive, consider and approve the audited financial results for the half year and year ended on 31st March, 2026 2. Other Business Agenda 3. Any other business with permission of Chairperson As intimated to you, vide letter dated March 28, 2026, the trading window for dealing in shares of the Company by the designated persons is already closed since April 01, 2026 until 48 hours of the declaration of financial results for the half year and year ended on March 31, 2026. Audited Standalone Financial Results of the company for the half year and year ended on March 31, 2026 along with Auditors Report under Reg 33 of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on: 21/05/2026) | ||
| Board Meeting | 14 Nov 2025 | 8 Nov 2025 |
| Broach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve We wish to inform the Exchange that the meeting of the Board of Directors of BROACH LIFECARE HOSPITAL LIMITED (the Company) is scheduled to be held on Friday November 14 2025 at 04.00 p.m. at the registered office situated at 501 5TH FLOOR CORPORATE HOUSE ABOVE BHARUCH ORTHOPAEDIC HOSPITAL R K CASTA BHARUCH-392001 GUJARAT INDIA to inter alia transact following business: 1. To consider and approve the unaudited financial results of the Company for the half year ended September 30 2025 2. Other Business as per Agenda of the Board meeting 3. Any other business with permission of Chairperson The Board of Directors of the Company at their meeting held today i.e. November 14, 2025, inter alia, duly approved and took on record the Unaudited Standalone Financial Results for the half year ended September 30, 2025. Please find enclosed herewith the duly signed Unaudited Financial Results for the half year ended September 30, 2025 along with the Limited Review Report. The same is also available on companys website i.e. www.maplehospital.in and on website of stock exchange, www.bseindia.com. The Board also noted that there is no deviation(s) or variation(s) in respect of the utilization of the proceeds of initial public offering (IPO) of the company during the period from April 01, 2025 to September 30, 2025. Statement of deviation(s) and variation(s) of funds raised through IPO (equity shares) is annexed herewith. The Company also appointed Internal auditor and secretarial auditor for FY 2025-26 (As per BSE Announcement dated on: 14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
